These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetized dogs under conditions of controlled coronary blood flow. D'Alonzo AJ, Hess TA, Darbenzio RB, Sewter JC. J Cardiovasc Pharmacol; 1993 Apr; 21(4):677-83. PubMed ID: 7681916 [Abstract] [Full Text] [Related]
3. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Carlsson L, Abrahamsson C, Drews L, Duker G. Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289 [Abstract] [Full Text] [Related]
4. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. D'Alonzo AJ, Darbenzio RB, Hess TA, Sewter JC, Sleph PG, Grover GJ. Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295 [Abstract] [Full Text] [Related]
6. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775 [Abstract] [Full Text] [Related]
11. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide. Gelband GH, McCullough JR. Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475 [Abstract] [Full Text] [Related]
12. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return. Gotanda K, Yokoyama H, Satoh K, Taira N. Cardiovasc Drugs Ther; 1989 Aug; 3(4):507-15. PubMed ID: 2488102 [Abstract] [Full Text] [Related]
13. Effects of several potassium channel openers and glibenclamide on the uterus of the rat. Piper I, Minshall E, Downing SJ, Hollingsworth M, Sadraei H. Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195 [Abstract] [Full Text] [Related]
14. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers. Lawson K, Barras M, Zazzi-Sudriez E, Martin DJ, Armstrong JM, Hicks PE. Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579 [Abstract] [Full Text] [Related]
15. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle. Yanagisawa T, Hashimoto H, Taira N. Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521 [Abstract] [Full Text] [Related]
16. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil. Taylor SG, Arch JR, Bond J, Buckle DR, Shaw DJ, Taylor JF, Ward JS. J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358 [Abstract] [Full Text] [Related]
18. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Di Diego JM, Antzelevitch C. Circulation; 1993 Sep; 88(3):1177-89. PubMed ID: 7689041 [Abstract] [Full Text] [Related]
19. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels. Stockbridge N, Zhang H, Weir B. Biochem Biophys Res Commun; 1991 Nov 27; 181(1):172-8. PubMed ID: 1958186 [Abstract] [Full Text] [Related]